NSAID, statin use may reduce risks for Barrett's patients

03/8/2010 | Medscape (free registration)

A study found Barrett's esophagus patients taking proton-pump inhibitors and either a nonsteroidal anti-inflammatory drug or a statin reduced their risk of esophageal adenocarcinoma. Data showed those who filled prescriptions for NSAID/aspirin were 36% less likely to have esophageal cancer and those who filled statin prescriptions had a 45% reduced risk.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA